Skip to main content

Peer Review reports

From: Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer

Original Submission
8 May 2021 Submitted Original manuscript
20 May 2021 Reviewed Reviewer Report
27 May 2021 Reviewed Reviewer Report
30 May 2021 Reviewed Reviewer Report
31 May 2021 Reviewed Reviewer Report
22 Jun 2021 Author responded Author comments - Gaoming Liao
Resubmission - Version 2
22 Jun 2021 Submitted Manuscript version 2
25 Jun 2021 Reviewed Reviewer Report
3 Jul 2021 Reviewed Reviewer Report
5 Jul 2021 Reviewed Reviewer Report
12 Jul 2021 Author responded Author comments - Gaoming Liao
Resubmission - Version 3
12 Jul 2021 Submitted Manuscript version 3
Publishing
20 Jul 2021 Editorially accepted
1 Sep 2021 Article published 10.1186/s12916-021-02068-4

You can find further information about peer review here.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us